Idi na sadržaj

Onkologija (pedijatrija)

Individualizirana/modificirana kemoterapija (prilagođavanje doza ili odgađanje terapije)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (otvara se novi prozor)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Izvor‎: N Engl J Med 1998;338(8):499-505.

Indeks‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (otvara se novi prozor)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (otvara se novi prozor)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Izvor‎: J Clin Oncol 2004;22(24):4888-92.

Indeks‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (otvara se novi prozor)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (otvara se novi prozor)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Izvor‎: JAMA Oncol 2022;8(1):79-87. 

Indeks‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (otvara se novi prozor)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (otvara se novi prozor)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Izvor‎: Haematologica 2000;85(11):1221-2.

Indeks‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (otvara se novi prozor)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (otvara se novi prozor)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Izvor‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indeks‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (otvara se novi prozor)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (otvara se novi prozor)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Izvor‎: Bone Marrow Transplant 2003;32(4):433-6.

Indeks‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (otvara se novi prozor)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (otvara se novi prozor)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Izvor‎: Bone Marrow Transplant 2005;36(8):715-20.

Indeks‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (otvara se novi prozor)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (otvara se novi prozor)

Zwaan CM, Kaspers GJ

Izvor‎: Br J Haematol 2004;127(3):264-79.

Indeks‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (otvara se novi prozor)